UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Haematologica (Roma), 2016-07, Vol.101 (7), p.803-811

2016

Volltextzugriff (PDF)

Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication

Bone marrow transplantation (Basingstoke), 2017-06, Vol.52 (6), p.832-838

2017

Volltextzugriff (PDF)

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2005-04, Vol.35 (8), p.737-746

2005

Volltextzugriff (PDF)

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (4), p.227-240

2008

Volltextzugriff (PDF)

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN

Transplant infectious disease, 2013-06, Vol.15 (3), p.219-232

2013

Volltextzugriff (PDF)

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8 and CD4 T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1437-1443

2011

Volltextzugriff (PDF)

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2001-09, Vol.28 (5), p.479-484

2001

Volltextzugriff (PDF)

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT

Bone marrow transplantation (Basingstoke), 2004-06, Vol.33 (11), p.1075-1081

2004

Volltextzugriff (PDF)

The first steps towards a diverse and inclusive EBMT: a position paper

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.343-346

2022

Volltextzugriff (PDF)

Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.298-300

2015

Volltextzugriff (PDF)

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

Haematologica (Roma), 2010-10, Vol.95 (10), p.1762-1768

2010

Volltextzugriff (PDF)

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8 and CD4 T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.543-549

2010

Volltextzugriff (PDF)

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

Clinical infectious diseases, 2017-12, Vol.65 (11), p.1819-1828

2017

Volltextzugriff (PDF)

Bloodstream infections among transplant recipients : Results of a nationwide surveillance in Spain

American journal of transplantation, 2007-11, Vol.7 (11), p.2579-2586

2007

Volltextzugriff (PDF)

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation

Transplant infectious disease, 2015-06, Vol.17 (3), p.361-370

2015

Volltextzugriff (PDF)

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.274-281

2015

Volltextzugriff (PDF)

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2001-08, Vol.28 (4), p.341-347

2001

Volltextzugriff (PDF)

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.79-82

2016

Volltextzugriff (PDF)

Tuberculosis after hematopoietic stem cell transplantation : incidence, clinical characteristics and outcome

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (3), p.291-298

2000

Volltextzugriff (PDF)

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT

Bone marrow transplantation (Basingstoke), 2010-05, Vol.45 (5), p.925-932

2010

Volltextzugriff (PDF)

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

Bone marrow transplantation (Basingstoke), 2023-12, Vol.58 (12), p.1348-1356

2023

Volltextzugriff (PDF)

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

Haematologica (Roma), 2011-08, Vol.96 (8), p.1231-1235

2011

Volltextzugriff (PDF)

A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1205-1211

2013

Volltextzugriff (PDF)

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection

Bone marrow transplantation (Basingstoke), 2011-11, Vol.46 (11), p.1484-1486

2011

Volltextzugriff (PDF)

Antifungal prophylaxis in haematology patients

Clinical microbiology and infection, 2006-12, Vol.12 (s7), p.65-76

De La Camara, R

2006

Volltextzugriff (PDF)

1 – 25 von 572

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(449)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines

Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN

Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8 and CD4 T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT

The first steps towards a diverse and inclusive EBMT: a position paper

Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8 and CD4 T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

Bloodstream infections among transplant recipients : Results of a nationwide surveillance in Spain

Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation

Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation

Tuberculosis after hematopoietic stem cell transplantation : incidence, clinical characteristics and outcome

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection

Antifungal prophylaxis in haematology patients

Suchergebnisse filtern